HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Morgan, L. Articles by Rutland, J. Search for Related Content PubMed PubMed Citation Articles by Morgan, L. Articles by Rutland, J.

Scintigraphic measurement of tracheal mucus velocity in vivo

¹ Dept of Thoracic Medicine, and ² Dept of Nuclear Medicine, Concord Repatriation General Hospital, Concord, and ³ Anatomy and Cell Biology, University of Melbourne, Parkville, Australia

CORRESPONDENCE: L. Morgan, Dept of Thoracic Medicine (C31), Concord Hospital, Hospital Rd, Concord NSW 2139, Australia. Fax: 61 297677605. E-mail: morganl@email.cs.nsw.gov.au

Keywords: chronic obstructive pulmonary disease, cilia, mucociliary clearance, tracheal mucus velocity

Received: July 10, 2002
Accepted December 8, 2003

Mucociliary clearance (MCC) is an important mechanism for removing inhaled particles, secretions and cellular debris from the respiratory tract. Here, a direct measurement of tracheal mucus velocity (TMV) for assessment of MCC, suitable for clinical and research use, is reported, and a comparison is made of TMV in normal subjects and patients with chronic obstructive pulmonary disease (COPD).

A 0.1-mL bolus of radiolabelled (2–5 MBq), technetium-labelled macroaggregated human albumin (^99mTc MAA) was injected through the cricothyroid membrane into the trachea of 20 young (<50 yrs) and 12 older (>50 yrs) normal subjects and 34 patients with COPD. Repeat studies were carried out in 13 normal subjects and 16 COPD patients. Movement of the bolus in the trachea was recorded (15 min) using a gamma camera interfaced to a computer. Data were analysed using specifically designed software.

The test was well tolerated by subjects and patients, and no significant adverse events were reported. No significant differences were observed between data recorded from different regions of the bolus (leading edge, peak, trailing edge) by analysis of variance (ANOVA). Bland-Altman plots of the repeat studies indicated that data were more variable in normal subjects (coefficient of repeatability (COR) 10.3 mm·min^–1) than in COPD patients (COR 5.5 mm·min^–1). TMV (mean±sd) in young normal subjects (n=20) was 10.7±3.5 mm·min^–1. TMV was reduced in older normal subjects (n=12; 6.5±2.6 mm·min^–1) and further reduced in COPD (n=34; 2.1±2.7 mm·min^–1).

In conclusion, this technique can be used to measure tracheal mucus velocity rapidly and safely in healthy subjects and patients with respiratory tract disease. This study has confirmed that tracheal mucus velocity declines with age and is further impaired in patients with chronic obstructive pulmonary disease.